6 assets in Opsoclonus-Myoclonus Syndrome

Therapeutic assets addressing Opsoclonus-Myoclonus Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Camustine Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Cytarabine Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Etoposide Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Melphalan Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Prednisone Opsoclonus-Myoclonus Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)